IRIS
MINISINI, Rosalba
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.356
NA - Nord America 2.711
AS - Asia 2.077
SA - Sud America 350
AF - Africa 80
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 1
Totale 8.585
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.616
SG - Singapore 778
IE - Irlanda 750
IT - Italia 684
DE - Germania 474
CN - Cina 351
HK - Hong Kong 342
SE - Svezia 319
BR - Brasile 281
RU - Federazione Russa 223
UA - Ucraina 218
FR - Francia 194
VN - Vietnam 187
IN - India 165
FI - Finlandia 144
CZ - Repubblica Ceca 94
GB - Regno Unito 89
KR - Corea 74
CA - Canada 58
ID - Indonesia 52
BJ - Benin 44
AT - Austria 37
PL - Polonia 33
TR - Turchia 28
ES - Italia 27
MX - Messico 27
NL - Olanda 24
AR - Argentina 23
BE - Belgio 19
BD - Bangladesh 18
ZA - Sudafrica 17
IR - Iran 16
JP - Giappone 15
EC - Ecuador 14
IQ - Iraq 11
LT - Lituania 9
EU - Europa 8
CO - Colombia 7
UZ - Uzbekistan 7
VE - Venezuela 7
CL - Cile 6
KE - Kenya 5
PY - Paraguay 5
AE - Emirati Arabi Uniti 4
EG - Egitto 4
IL - Israele 4
CH - Svizzera 3
JM - Giamaica 3
MA - Marocco 3
PE - Perù 3
PK - Pakistan 3
PT - Portogallo 3
SA - Arabia Saudita 3
TN - Tunisia 3
UY - Uruguay 3
AL - Albania 2
AM - Armenia 2
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
DZ - Algeria 2
GT - Guatemala 2
KZ - Kazakistan 2
LB - Libano 2
NP - Nepal 2
OM - Oman 2
PA - Panama 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
AU - Australia 1
BG - Bulgaria 1
BO - Bolivia 1
BY - Bielorussia 1
DO - Repubblica Dominicana 1
GE - Georgia 1
GI - Gibilterra 1
HU - Ungheria 1
LK - Sri Lanka 1
LV - Lettonia 1
MD - Moldavia 1
PH - Filippine 1
PS - Palestinian Territory 1
RO - Romania 1
SI - Slovenia 1
SN - Senegal 1
TH - Thailandia 1
YT - Mayotte 1
Totale 8.585
Salva come PNG Salva come JPEG
Città #
Dublin 738
Jacksonville 368
Hong Kong 341
Singapore 238
Ashburn 222
Dearborn 182
Beijing 177
Novara 140
Chandler 132
Los Angeles 104
Piemonte 97
Milan 89
Wilmington 87
Moscow 84
Lawrence 81
Princeton 81
Munich 79
Seoul 68
Ann Arbor 67
San Mateo 59
Buffalo 57
Ho Chi Minh City 55
Turin 53
New York 52
São Paulo 46
Cotonou 44
Hanoi 41
Jakarta 41
Andover 38
Vercelli 38
Brno 35
Nuremberg 35
Pardubice 34
Brooklyn 28
Denver 28
Frankfurt am Main 28
Helsinki 27
Boardman 25
Warsaw 25
Santa Clara 24
Chennai 23
Dallas 23
London 23
Bremen 21
Houston 20
Brussels 19
Montreal 19
Nanjing 19
Turku 19
Poplar 18
Stockholm 18
Atlanta 17
Falkenstein 17
Amsterdam 16
Düsseldorf 16
Orem 16
Chicago 15
Toronto 15
Tokyo 14
České Budějovice 14
Mexico City 13
Vienna 13
Johannesburg 12
Redondo Beach 12
Biên Hòa 11
Mumbai 11
Phoenix 11
Seattle 11
Boston 10
Dong Ket 10
Mülheim 10
Bologna 9
Brescia 9
Cassano Magnago 9
Jinan 9
Norwalk 9
Ottawa 9
Ankara 8
Charlotte 8
Manchester 8
New Delhi 8
Stankov 8
Tianjin 8
West Jordan 8
Brasília 7
Curitiba 7
Guayaquil 7
Hefei 7
Palermo 7
Rome 7
Tashkent 7
Assago 6
Augusta 6
Fairfield 6
Guangzhou 6
Kunming 6
Ninh Bình 6
Porto Alegre 6
Roubaix 6
Salvador 6
Totale 4.887
Salva come PNG Salva come JPEG
Nome #
Genetic polymorphisms of inflammatory cytokines and liver fibrosis progression due to recurrent hepatitis C 208
Gas6 as a predictor of esophageal varices in patients affected by hepatitis C virus related-chronic liver disease 139
rs1801253 Gly/Gly carriage in the ADRB1 gene leads to unbalanced cardiac sympathetic modulation as assessed by spectral analysis of heart rate variability 133
Levosimendan inhibits peroxidation in hepatocytes by modulating apoptosis/autophagy interplay. 131
Japanese encephalitis virus RNA detected in Culex pipiens mosquitoes in Italy 126
Treatment failure after interferon-free treatment of hepatitis C as a clue of a yet undetected hepatocellular carcinoma 124
Clinical Relevance of Liver Involvement in the Clinical Course of Systemic Sclerosis 124
Response rates to direct antiviral agents among hepatitis C virus infected patients who develop hepatocellular carcinoma following direct antiviral agents treatment 123
Ongoing Mycophenolate Treatment Impairs Anti-SARS-CoV-2 Vaccination Response in Patients Affected by Chronic Inflammatory Autoimmune Diseases or Liver Transplantation Recipients: Results of the RIVALSA Prospective Cohort 122
Effect of Lactoferrin on Clinical Outcomes of Hospitalized Patients with COVID-19: The LAC Randomized Clinical Trial 120
Antiviral treatment of hepatitis C improves glucose metabolism along the entire spectrum from normal glucose tolerance to diabetes 111
Prognostic Markers in Hospitalized COVID-19 Patients: The Role of IP-10 and C-Reactive Protein 111
CGRP Plasma Levels Correlate with the Clinical Evolution and Prognosis of Hospitalized Acute COVID-19 Patients 110
Interplay of PNPLA3 and HSD17B13 Variants in Modulating the Risk of Hepatocellular Carcinoma among Hepatitis C Patients 110
Analysis of beta1 and beta2-adrenergic receptors polymorphism in patients with apical ballooning cardiomyopathy 107
Oxidative Stress in Non-Alcoholic Fatty Liver Disease 106
Influence of age on sex-related differences among patients with hepatitis C. 103
Evaluation of the red cell distribution width as a biomarker of early mortality in hepatocellular carcinoma 102
Baseline Plasma Gas6 Protein Elevation Predicts Adverse Outcomes in Hospitalized COVID-19 Patients 102
17,β-estradiol inhibits hepatitis C virus mainly by interference with the release phase of its life cycle 100
Improvement of insulin sensitivity in diabetic and non diabetic patients with chronic hepatitis C treated with direct antiviral agents 100
Identification of mutations in circulating cell-free tumour DNA as a biomarker in hepatocellular carcinoma 98
Increased Levels of ICOS and ICOSL Are Associated to Pulmonary Arterial Hypertension in Patients Affected by Connective Tissue Diseases 97
Decreased Gas6 and sAxl Plasma Levels Are Associated with Hair Loss in COVID-19 Survivors 96
SARS-CoV-2 infection risk is higher in vaccinated patients with inflammatory autoimmune diseases or liver transplantation treated with mycophenolate due to an impaired antiviral immune response: results of the extended follow up of the RIVALSA prospective cohort 95
Role of Osteopontin as a Potential Biomarker of Pulmonary Arterial Hypertension in Patients with Systemic Sclerosis and Other Connective Tissue Diseases (CTDs) 95
Determinants of long COVID among adults hospitalized for SARS-CoV-2 infection: A prospective cohort study 93
Assessment of liver fibrosis progression in patients with chronic hepatitis C and normal alanine aminotransferase values: the role of the AST to platelet ratio index 93
Detrimental Impact of Interferon-Based Regimens for Chronic Hepatitis C on Vitamin D/Parathyroid Hormone Homeostasis 93
Recent advances in HCV entry 91
Gas6 as a putative noninvasive biomarker of hepatic fibrosis 91
Understanding protection from SARS-CoV-2 using metabolomics 91
APOLIPOPROTEIN E GENOTYPES MODULATE FIBROSIS PROGRESSION IN PATIENTS WITH CHRONIC HEPATITIS C AND PERSISTENTLY NORMAL TRANSAMINASES 91
ACE genotype, body weight changes and target organ damage in renal transplant recipients 91
IL28B Polymorphism, Blood Interferon-alpha Concentration, and Disease Stage of HCV Mono-infected and HCV-HIV Co-infected Patients. 90
17β-Oestradiol Protects from Hepatitis C Virus Infection through Induction of Type I Interferon 89
Interferon alpha concentrations in blood and peritoneal fluid during treatment for hepatitis C 89
Cardiac dysfunction as an early predictor of portal hypertension in chronic hepatitis C 89
Severity of nonalcoholic fatty liver disease in type 2 diabetes mellitus: Relationship between nongenetic factors and PNPLA3/HSD17B13 polymorphisms 89
Liver stiffness, not fat liver content, predicts the length of QTc interval in patients with chronic liver disease 89
Carriage of the apolipoprotein E-epsilon4 allele and histologic outcome of recurrent hepatitis C after antiviral treatment 88
Periostin Circulating Levels and Genetic Variants in Patients with Non-Alcoholic Fatty Liver Disease 88
Baseline plasma SARS-CoV-2 RNA detection predicts an adverse COVID-19 evolution in moderate to severe hospitalized patients 87
Baseline Plasma Osteopontin Protein Elevation Predicts Adverse Outcomes in Hospitalized COVID-19 Patients 86
L’impatto del Long COVID è stato minore nella terza ondata della pandemia rispetto alla prima ondata in una popolazione italiana di 324 pazienti. 86
Fibrosis Progression in HCV Carriers with Mild Hepatitis Who Possess the High-Repetition Variant of the DRD4 Gene, a Genetic Marker for Binge-Drinking and Risk-Seeking Behavior: A Longitudinal Study. 86
Can apical ballooning cardiomyopathy and anterior STEMI be differentiated based on β1 and β2-adrenergic receptors polymorphisms? 85
Occult hepatitis B virus infection of peripheral blood mononuclear cells among treatment-naïve patients with chronic lymphocytic leukemia 84
Interferon-stimulated gene pathways in the treatment of viral hepatitis 83
Gas6/TAM system: potential prognostic biomarker for Multiple Sclerosis 82
Low fibrosis progression of recurrent hepatitis C in apolipoprotein E epsilon4 carriers: relationship with the blood lipid profile 82
Modulation of Oxidative Stress by 17 β-Estradiol and Genistein in Human Hepatic Cell Lines In Vitro 82
Combinatorial use of single nucleotide polymorphisms to help predict liver fibrosis in patients with hepatitis C infections 80
HBV AND LYMPHOMAGENESIS: NOVEL INSIGHTS INTO AN OCCULT RELATIONSHIP 79
Role of Gas6 and TAM Receptors in the Identification of Cardiopulmonary Involvement in Systemic Sclerosis and Scleroderma Spectrum Disorders 79
HSD17B13 and other liver fat-modulating genes predict development of hepatocellular carcinoma among HCV-positive cirrhotics with and without viral clearance after DAA treatment 78
Genetic polymorphisms of interleukin-6 modulate fibrosis progression in mild chronic hepatitis C. 77
Influence of angiotensin-converting enzyme I/D gene polymorphism on clinical and histological correlates of chronic hepatitis C 74
INTERLEUKIN 6 PROMOTER POLYMORPHISMS INFLUENCE THE OUTCOME OF CHRONIC HEPATITIS C 74
Early activation of interferon-stimulated genes in human liver allografts: relationship with acute rejection and histological outcome 73
Circadian control of hepatitis B virus replication 73
Hepatitis B virus and lymphomagenesis: novel insights into an occult relationship 72
Unsuspected strongyloidiasis in hospitalized elderly patients with and without eosinophilia 70
Finding the seed of recurrence: Hepatocellular carcinoma circulating tumor cells and their potential to drive the surgical treatment 70
COVID-19 Biomarkers at the Crossroad between Patient Stratification and Targeted Therapy: The Role of Validated and Proposed Parameters 69
Excess body weight, liver steatosis, and early fibrosis progression due to hepatitis C recurrence after liver transplantation 69
Lower Circulating Gas6 Levels Are Associated with Bulbar Phenotype and Faster Disease Progression in Amyotrophic Lateral Sclerosis Patients 67
Direct antivirals and cognitive impairment in hepatitis C: a clinical-neurophysiologic study 67
Plasma Pattern of Extracellular Vesicles Isolated from Hepatitis C Virus Patients and Their Effects on Human Vascular Endothelial Cells 66
GENETIC POLYMORPHISM AT THE APOLIPOPROTEIN E LOCUS AFFECTS THE OUTCOME OF CHRONIC HEPATITIS B 66
Methylenetetrahydrofolate reductase C677T polymorphism and liver fibrosis progression in patients with recurrent hepatitis C 66
Reference values of one-point carotid stiffness parameters determined by carotid echo-tracking and brachial pulse pressure in a large population of healthy subjects 66
T-cell mediated responses against alpha-foetoprotein in hepatocellular carcinoma: Relationship with hepatitis C virus infection, tumour phenotype and patients’ survival 66
Extracellular Vesicles as a Potential Biomarker of Pulmonary Arterial Hypertension in Systemic Sclerosis 65
Gas6/TAM system as potential biomarker for multiple sclerosis prognosis 65
Evaluation of donor hepatic iron concentration as a factor of early fibrotic progression after liver transplantation 65
Inflammatory Gene Expression Associates with Hepatitis B Virus cccDNA- but Not Integrant-Derived Transcripts in HBeAg Negative Disease 64
Robust and persistent b-and t-cell responses after covid-19 in immunocompetent and solid organ transplant recipient patients 64
TGF-beta1 genotypes in cirrhosis: relationship with the occurrence of liver cancer 63
Exposure to Plasma From Non-alcoholic Fatty Liver Disease Patients Affects Hepatocyte Viability, Generates Mitochondrial Dysfunction, and Modulates Pathways Involved in Fat Accumulation and Inflammation 60
Role of Interleukin 28B rs12979860 C/T Polymorphism on the Histological Outcome of Chronic Hepatitis C: Relationship with Gender and Viral Genotype 59
Spleen stiffness measurement predicts decompensation and rules out high-risk oesophageal varices in primary biliary cholangitis 59
Usefulness of six non-proprietary indirect markers of liver fibrosis in patients with chronic hepatitis C 57
Role of AST to platelet ratio index in the detection of liver fibrosis in patients with recurrent hepatitis C after liver transplantation 57
INTERLEUKIN-6 POLYMORPHISMS AND GENDER: RELATIONSHIP WITH THE OCCURRENCE OF HEPATOCELLULAR CARCINOMA IN PATIENTS WITH END-STAGE LIVER DISEASE 56
Inflammatory and Immune Responses during SARS-CoV-2 Infection in Vaccinated and Non-Vaccinated Pregnant Women and Their Newborns 55
IL-28B rs12979860 C/T allele distribution in patients with liver cirrhosis: role in the course of chronic viral hepatitis and the development of HCC 55
Vitamin D receptor gene polymorphisms and hepatocellular carcinoma in alcoholic cirrhosis 55
Occult hepatitis B virus infection in liver transplant recipients with recurrent hepatitis C: relationship with donor age and fibrosis progression 55
Pegylated Vs. conventional interferon–alpha in antiviral regimens for recurrent hepatitis C: a comparison of tolerability and efficacy 54
Prevalence and risk factors for delayed adrenal insufficiency after liver transplantation. Liver Transpl. 2008 Jul;14(7):1014-9 54
Prevalence and clinical relevance of occult hepatitis B virus infection in patients on the waiting list for kidney transplantation 54
GENDER-RELATED DISTRIBUTION OF THE INTERLEUKIN-1BETA AND INTERLEUKIN-1 RECEPTOR ANTAGONIST GENE POLYMORPHISMS IN PATIENTS WITH END-STAGE LIVER DISEASE 54
Phenotypic Characteristics of the Tumour Microenvironment in Primary and Secondary Hepatocellular Carcinoma 54
Risk of hepatocellular carcinoma and death among cirrhotics who carry genetic variants of epidermal growth factor, Adiponutrin and 17β-Hydroxysteroid Dehydrogenase-13: a long-term cohort study 53
Identification of a Functional, CRM-1-Dependent Nuclear Export Signal in Hepatitis C Virus Core Protein 53
Sex-related influence of angiotensin-converting enzyme polymorphisms on fibrosis progression due to recurrent hepatitis C after liver transplantation 53
Mechanisms of Resistance to Immunotherapy in Hepatocellular Carcinoma 52
MTHFR C677T Polymorphism and Risk of HCC in Patients With Liver Cirrhosis: Role of Male Gender and Alcohol Consumption 52
Weight gain after liver transplantation and the I/D polymorphism of the angiotensin-converting enzyme gene 52
Totale 8.321
Salva come PNG Salva come JPEG
Categoria #
all - tutte 49.595
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.595
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021293 0 0 0 0 0 32 74 6 75 15 77 14
2021/2022535 11 23 80 39 29 0 46 19 43 40 81 124
2022/20231.513 153 74 84 16 69 116 59 52 762 13 81 34
2023/2024919 54 108 51 25 152 39 186 29 23 43 68 141
2024/20251.687 41 30 91 33 55 91 188 164 341 120 153 380
2025/20262.371 265 215 301 750 607 233 0 0 0 0 0 0
Totale 8.793